학술논문
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
Document Type
Article
Author
Hurvitz, S.A.; Bardia, A.; Quiroga, V.; Blancas, I.; Alonso-Romero, J.L.; Zamora-Auñón, P.; Park, Y.H.; Vasiliev, A.; Adamchuk, H.; Salgado, M.; Yardley, D.A.; Berzoy, O.; Chan, D.; Spera, G.; Xue, C.; Ferreira, E.; Badovinac Crnjevic, T.; López-Valverde, V.; Steinseifer, J.; Pérez-Moreno, P.D.; Fernando, T.M.; Moore, H.M.; Fasching, P.A.
Source
In: The Lancet Oncology . (The Lancet Oncology, September 2023, 24(9):1029-1041)
Subject
Language
English
ISSN
14745488
14702045
14702045